John Paulson’s Takeda Pharmaceutical TAK Stock Holding History

John Paulson’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,727,415	Closed	-$86.3M	–	42
2021 Q1	$86.3M	Sell	4,727,415 -6,568,431	-58%	-$118M	1.98%	13
2020 Q4	$206M	Hold	11,295,846	–	–	5.34%	7
2020 Q3	$202M	Sell	11,295,846 -191,059	-2%	-$3.48M	6.28%	6
2020 Q2	$206M	Sell	11,486,905 -1,757,806	-13%	-$31.6M	6.58%	5
2020 Q1	$201M	Hold	13,244,711	–	–	7.67%	4
2019 Q4	$261M	Hold	13,244,711	–	–	5.64%	7
2019 Q3	$228M	Hold	13,244,711	–	–	4.56%	8
2019 Q2	$234M	Hold	13,244,711	–	–	3.98%	7
2019 Q1	$270M	Buy	+13,244,711	New	+$267M	5.66%	7

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

John Paulson's TAK Position: Q2 2021 in Review

John Paulson sold out of Takeda Pharmaceutical (TAK) in Q2 2021, closing a stake of 4,727,415 shares — an estimated $86.3M sold.

John Paulson first reported a position in TAK in Q1 2019 and held it in 9 quarters. The position peaked at $270M in Q1 2019. 305 funds tracked by Wall St. Rank hold TAK as of Q2 2021.

John Paulson reported no remaining Takeda Pharmaceutical position as of Q2 2021 after selling out during the quarter.
John Paulson sold 4,727,415 Takeda Pharmaceutical shares in Q2 2021, an estimated $86.3M.
John Paulson first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 9 quarters.
John Paulson's Takeda Pharmaceutical position peaked at $270M in Q1 2019.
305 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2021.

Based on Paulson & Co's 13F filing for Q2 2021, filed 16 Aug 2021.